Protease resistant modified interferon alpha polypeptides
US7611700B2 · kind B2 · utility
21Cited by
85References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2003 |
| Grant date | Nov 3, 2009 |
| Priority date | — |
| Expiry date | Jan 19, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Processes and systems for the high throughput directed evolution of peptides and proteins, particularly cytokines that act in complex biological settings, are provided. Also provided is a rational method for generating protein variants and the resulting variants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.